UBS Lux Equity Fund Biotech USD vs Protean Select

UBS Lux Equity Fund Biotech USD vs Protean Select

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

2. Protean Select

  • Security

    Protean Select

  • Fee

    2.60%

  • ISIN

    SE0017830748

  • Holdings

    21

Fund Holdings

We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.9) and Moderna (9.21). In comparison with Protean Select, we have 22 holdings where RaySearch is the largest holding (4.07), followed by Hexagon (4.04) and Ambea (3.99).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Protean Select.

UBS Lux Equity Fund Biotech USD Protean Select
1. Regeneron Pharmaceuticals Inc
10.04 %
1. RaySearch Laboratories B
4.07 %
2. Vertex Pharmaceuticals Inc
9.9 %
2. Hexagon B
Sweden
4.04 %
3. Moderna Inc
9.21 %
3. Ambea
3.99 %
4. Alnylam Pharmaceuticals Inc
6.54 %
4. Nordea Bank Abp
Finland
3.98 %
5. AbbVie Inc
USA
5.52 %
5. Getinge B
Sweden
3.26 %
6. Gilead Sciences Inc
USA
4.66 %
6. Lindex Group
Finland
3.26 %
7. Amgen Inc
4.32 %
7. Devyser Diagnostics AB
Sweden
3.18 %
8. BioNTech SE
4.13 %
8. Acast AB
Sweden
3.11 %
9. Karuna Therapeutics Inc
3.75 %
9. Huhtamäki Oyj
Finland
3.1 %
10. Royalty Pharma Plc
3.28 %
10. Essity B
Sweden
3.01 %
- 11. Mowi
Norway
3.01 %
- 12. Tryg A/S
Denmark
2.99 %
- 13. Sampo Oyj A
Finland
2.97 %
- 14. Skanska B
Sweden
2.84 %
- 15. Elekta B
Sweden
2.62 %
- 16. Atlas Copco B
Sweden
2.41 %
- 17. MEKO Sweden AB
Sweden
2.29 %
- 18. Coor Service Management Holding
2.21 %
- 19. Lagercrantz Group B
Sweden
2.19 %
- 20. Novo Nordisk B
Denmark
2.08 %
- 21. Indutrade AB
Sweden
2.07 %

The list of fund holdings was last updated on April 17, 2025.